Malaysia

Health Ministry bans three cosmetic products over presence of scheduled poisons

Clindamycin, mercury and other restricted substances found in products now withdrawn from Malaysian market

Updated 1 year ago · Published on 15 May 2025 6:51PM

Health Ministry bans three cosmetic products over presence of scheduled poisons
MOH has urged the public to immediately stop using the affected products and to consult a medical professional should they experience any discomfort or adverse reactions - May 15, 2025

THE Ministry of Health (MOH) has withdrawn the notification of three cosmetic products in Malaysia after they were found to contain scheduled poisons, including pharmaceutical-grade substances and mercury.

In a statement issued today, MOH confirmed that Hebe - Micro Rescue Cream (Reduce Acne Scar) and Cloroc Reju Cream were found to contain Clindamycin, Metronidazole, Tretinoin, and Betamethasone 17-valerate—ingredients classified as medicinal compounds requiring regulatory approval and professional oversight.

“Products containing Clindamycin, Metronidazole, Tretinoin, and Betamethasone 17-valerate are classified as medicines that must be registered with the Drug Control Authority and can only be used under the supervision of qualified healthcare professionals,” the ministry said.

The notification for another product, Seri Ayu Secret-Radiant Repair Cream, has also been revoked after it was found to contain mercury, a banned ingredient in cosmetic formulations due to its toxic effects.

“Mercury is prohibited in cosmetic products as it can be absorbed into the body and may cause damage to the kidneys and nervous system,” the ministry added.

MOH has urged the public to immediately stop using the affected products and to consult a medical professional should they experience any discomfort or adverse reactions. Sellers and distributors have been ordered to cease all sales and distribution of the products concerned.

Legal action may be taken against those found in breach of the law. Individuals convicted for a first offence may face a fine of up to RM25,000 or imprisonment for up to three years, or both. Repeat offenders may face fines of up to RM50,000 or five years’ imprisonment. Companies may be fined up to RM50,000 for a first offence, and up to RM100,000 for subsequent offences.

Consumers are advised to verify the status of cosmetic products by visiting the National Pharmaceutical Regulatory Agency (NPRA) website at [www.npra.gov.my](http://www.npra.gov.my) or by using the ‘NPRA Product Status’ mobile application, available on the Google Play Store.  May 15, 2025

Spotlight

Malaysia

Young Malaysians record highest rates of depression - Dr Dzulkefly

By Alfian Z.M. Tahir

Malaysia

Bandar Utama schoolgirl stabbing: Court allows media coverage, orders teenager’s identity protected

Malaysia

LLM apologises for TuJu navigation disruptions amid surge in users

By Alfian Z.M. Tahir

Malaysia

3,510 medical officers resign, more than half join private sector

Malaysia

Police await AGC’s directions on Negeri Sembilan MB’s forced-signature claim

Malaysia

Truck drivers top list of motorists caught driving under influence of drugs in Penang

Malaysia

Govt approves 17 measures to tighten airport security after alleged drug-smuggling case

Malaysia

Waze ban driven by legal, data security concerns, says Gobind

Malaysia

Police to disclose findings on Kuching school attack next Tuesday

You may be interested

Malaysia

Zakir Naik rules out return to India while BJP remains in power

By Alfian Z.M. Tahir

Malaysia

PH to contest Melaka polls solo, rules out cooperation with Bersatu

Malaysia

Man jailed for 9 months after admitting to stealing women's undergarments at laundromat

Malaysia

Pahang Ruler warns youths against hate speech, social ills

Malaysia

Two held after 16-year-old girl rescued in suspected sex exploitation case

Malaysia

Rumours of Sarawak DUN dissolution rife; To be announced tomorrow?

Malaysia

Takiyuddin blames Bersatu for PN deregistration

Malaysia

Commercial interests of insurance companies must not take precedence over patients' welfare – MMA